Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin.
Heiss G, Wallace R, Anderson GL, Aragaki A, Beresford SA, Brzyski R, Chlebowski RT, Gass M, LaCroix A, Manson JE, Prentice RL, Rossouw J, Stefanick ML; WHI Investigators.
Heiss G, et al. Among authors: wallace r.
JAMA. 2008 Mar 5;299(9):1036-45. doi: 10.1001/jama.299.9.1036.
JAMA. 2008.
PMID: 18319414
Clinical Trial.